Cargando…

Effects of COVID-19 pandemic on the management of pulmonary hypertension

The coronavirus of 2019 (COVID-19) disrupted delivery of healthcare. Patients with pulmonary hypertension (PH), especially pulmonary arterial hypertension (PAH), require significant resources for both diagnosis and management and are at high risk for decompensation due to disruption in their care. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Christine Y., Sahay, Sandeep, Shlobin, Oksana, Soto, Francisco J., Mathai, Stephen C., Melendres-Groves, Lana, Mullin, Christopher J., Levine, Deborah J., Kay, Dana, Highland, Kristin, Bossone, Eduardo, Poms, Abby, Memon, Humna, Balasubramanian, Vijay, Farmer, Mary Jo S., Rahaghi, Franck, Elwing, Jean M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699715/ https://www.ncbi.nlm.nih.gov/pubmed/36493604 http://dx.doi.org/10.1016/j.rmed.2022.107061

Ejemplares similares

Utilization of risk assessment tools in management of PAH: A PAH provider survey
por: Sahay, Sandeep, et al.
Publicado: (2022)

Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
por: Kingrey, John F., et al.
Publicado: (2023)

Real-world experience using combination therapy with riociguat and risk assessment using REVEAL Lite 2.0 in patients with pulmonary arterial hypertension
por: Sahay, Sandeep, et al.
Publicado: (2020)

Real-world experience with riociguat as potential bridging therapy in patients with chronic thromboembolic pulmonary hypertension: a case series
por: Balasubramanian, Vijay P., et al.
Publicado: (2020)

Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
por: Balasubramanian, Vijay P., et al.
Publicado: (2022)

Barriers and facilitators to interhospital transfer of acute pulmonary embolism: An inductive qualitative analysis
por: DeBerry, Jacob, et al.
Publicado: (2023)

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
por: Rahaghi, Franck F., et al.
Publicado: (2022)

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation
por: Rahaghi, Franck F., et al.
Publicado: (2017)

Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic
por: Ryan, John J., et al.
Publicado: (2020)

Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat
por: Rahaghi, Franck F., et al.
Publicado: (2022)

Alpha-1 antitrypsin deficiency research and emerging treatment strategies: what’s down the road?
por: Rahaghi, Franck F.
Publicado: (2021)

Use of Extracorporeal Membrane Oxygenation in Postpartum Management of a Patient with Pulmonary Arterial Hypertension
por: Abid Memon, Humna, et al.
Publicado: (2018)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
por: Rahaghi, Franck F., et al.
Publicado: (2017)

Teppanyaki/Hibachi Pneumonitis: An Exotic Cause of Exogenous Lipoid Pneumonia
por: Rahaghi, Franck, et al.
Publicado: (2016)

Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
por: Rahaghi, Franck, et al.
Publicado: (2021)

High geographic prevalence of pulmonary artery hypertension: associations with ethnicity, drug use, and altitude
por: Dubroff, Jason, et al.
Publicado: (2020)

Clinical phenotyping: role in treatment decisions in sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2020)

The Rapid Initiation, Titration, and Transition from Intravenous to Oral Treprostinil in a Patient with Severe Pulmonary Arterial Hypertension
por: Gleason, James Benjamin, et al.
Publicado: (2015)

Pulmonary hypertension associated with COPD
por: Elwing, Jean, et al.
Publicado: (2008)

Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
por: Rahaghi, Franck F, et al.
Publicado: (2020)

Corrigendum for health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry
por: Minhas, J., et al.
Publicado: (2022)

Airbag Pneumonitis
por: Govindarajan, Raghav, et al.
Publicado: (2010)

Hemothorax following lung transplantation: incidence, risk factors, and effect on morbidity and mortality
por: Hong, Aria, et al.
Publicado: (2016)

Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications
por: Nadipelli, Vijay R., et al.
Publicado: (2022)

Chlorpheniramine Maleate Throat Spray for the Treatment of COVID-19-Induced Acute Viral Pharyngitis: Case Series
por: Tesch, Mari L, et al.
Publicado: (2023)

Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)
por: Minhas, Jasleen, et al.
Publicado: (2021)

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
por: Rahaghi, Franck F., et al.
Publicado: (2023)

NATO Advanced Study Institute an Spectrocopic and Diffraction Techniques in Interfacial Electrochemistry
por: Gutiérrez, C, et al.
Publicado: (1990)

NATO Advanced Research Workshop on Synchrotron Techniques in Interfacial Electrochemistry
por: Melendres, Carlos, et al.
Publicado: (1994)

Algorithms for Worst-Case Design and Applications to Risk Management
por: Rustem, Berc, et al.
Publicado: (2001)

Multiomics tools for the diagnosis and treatment of rare neurological disease
por: Crowther, L. M., et al.
Publicado: (2018)

13th International Conference on Information Security : IFIP SEC '97
por: Highland, H J
Publicado: (1997)

The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
por: Bajwa, Abubakr A., et al.
Publicado: (2017)

Pulse dose steroids in severe pulmonary arterial hypertension secondary to systemic lupus erythematosus
por: Lee, Cody, et al.
Publicado: (2017)

Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease
por: Mucalo, Lana, et al.
Publicado: (2023)

Reducing rates of readmission and development of an outpatient management plan in pulmonary hypertension: lessons from congestive heart failure management
por: Dolan, Justin, et al.
Publicado: (2020)

Understanding GPCR recognition and folding from NMR studies of fragments
por: Marino, Jacopo, et al.
Publicado: (2018)

Safety of macitentan for the treatment of pulmonary hypertension: Real‐world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)
por: McLaughlin, Vallerie V., et al.
Publicado: (2022)

Fundamentals of Oncologic PET-CT Reporting
por: Bijan, Bijan, et al.
Publicado: (2013)

COVID-19 en la mortalidad materna, perinatal y neonatal de cuatro localidades de Bogotá. Estudio descriptivo.
por: Ardila Pereira, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ap3caul8v5m9u1vf045na0jv7b